保加利亚乳杆菌微胶囊化工艺研究

目的制备保加利亚乳杆菌微胶囊,提高菌株的酸、热耐受性及降低菌体的分离成本。方法以保加利亚乳杆菌(Lactobacillus bulgaricus)为研究对象,海藻酸钠(SA)为壳材、CaCl2为固化剂,制备保加利亚乳杆菌微胶囊;包埋率、颗粒平均化程度、机械强度等为考核指标,研究保加利亚乳杆菌微胶囊化的工艺。结果当海藻酸钠浓度为0.75%、CaCl2浓度为3%、电压为600V、泵速为1.96mL/min、震动频率为80Hz时,微胶囊化包埋效果最佳,经固定化后的菌微胶囊保持了良好的保加利亚乳杆菌的活性,微囊化保加利亚乳杆菌经过2次连续发酵后的产酸量分别达到59.4g/L和55.8g/L。结论本研究为工业化生产乳酸提供了一条具有经济价值的途径。     

增强微胶囊在血液中稳定性的研究

目的:通过改进成膜工艺,减少血液中HCO3-对海藻酸钠-ε-聚赖氨酸(ε-AP)微胶囊稳定性的影响,从而增强ε-AP微胶囊在血液中的稳定性,使其能够应用于生物人工肝血浆/血液灌注。方法:改进成膜工艺:在成膜液中添加10 mmol/L的Na HCO3并增加ε-聚赖氨酸反应浓度来制备ε-AP微胶囊,用膨胀度表征其机械强度,荧光标记的牛血清白蛋白(FITC-BSA)检测其通透性能,并以微胶囊的膨胀度变化作为衡量指标,考察微胶囊在Na HCO3溶液和血清中的稳定性。结果:改进成膜工艺制备的ε-AP微胶囊与常规条件制备的微胶囊具有接近的机械强度和通透性;改进成膜工艺能够增强的ε-AP微胶囊在Na HCO3溶液和血清中的稳定性;常规条件制备的ε-AP微胶囊在血清中膨胀度增加了约560%,而改进成膜工艺制备的微胶囊膨胀度仅增加160%,其稳定性显著增强。结论:改进成膜工艺能够增强ε-AP微胶囊在血液中的稳定性。     

海藻酸钙凝胶包埋法制备固定化小球藻

采用海藻酸钙凝胶包埋法对普通小球藻进行固定化,考察了海藻酸钠浓度、Ca Cl2浓度、胶球直径和胶球培养密度对固定化小球藻生长的影响,比较了游离和固定化小球藻细胞的生长特性,并测试了固定化小球藻的连续培养性能。结果表明,小球藻适宜的固定化条件为:海藻酸钠浓度2%(W/V)、Ca Cl2浓度1.5%(W/V)、凝胶球直径3 mm、凝胶球培养密度200粒/100 m L;与游离态小球藻相比,固定化小球藻的生长周期较长,在对数期后期和稳定期的生长态势优于游离态细胞,并可实现重复循环利用;连续培养实验显示,在优化条件下制备的固定化小球藻可连续使用200 h左右,有望用于生物催化和生物转化中的连续反应体系。     

SA/NaCS-PDMDAAC微胶囊固定化酵母细胞合成胞苷三磷酸

通过海藻酸钠/纤维素硫酸钠-聚二甲基二烯丙基氯化铵(SA/NaCS-PDMDAAC)微胶囊固定化酵母细胞将胞苷一磷酸(CMP)转化为胞苷三磷酸(CTP),考察了各种因素条件对CTP转化率的影响,以提高CTP的转化率.通过考察分批补料添加葡萄糖,固定化酵母量,CMP浓度等以达到提高CTP转化率的要求.结果在250 mL锥...     

酪氨酸酚裂解酶的固定化与转化条件的优化

以欧文氏菌(Erwinia herbicola)来源的酪氨酸酚裂解酶的重组大肠埃希菌Escherichia coli BL21为研究对象,研究固定化大肠埃希菌生产L-酪氨酸的条件。以海藻酸钠为载体,采用单因素实验分别考察了载体材料、明胶浓度、反应时间、苯酚浓度和辅助剂(二氧化硅、硅藻土和碳酸钙)等因素对L-酪氨酸生产的影响,发现明胶浓度、反应时间、苯酚和碳酸钙等因素的影响较为显著,进而通过正交实验探索最优条件。结果表明,生产L-酪氨酸的最优条件:载体为4%海藻酸钠与6%明胶的混合载体,苯酚浓度0.08 mol/L,反应时间8 h,于载体中添加0.6%碳酸钙。此条件下,连续反应9次后L-酪氨酸的产量达到64.5 g/L,比优化前提高了451.3%。     

固定化葡萄糖异构酶的研究

采用明胶包埋经热固定处理的链霉菌细胞,再用戊二醛交联的复合法制备固定化葡酶糠异构酶。选择了合适的包埋配比和戊二醛交联的最适条件。确定了制备固定化酶的工艺条件。对固定化酶的若干性质进行了试验研究,选择了一个较理想的转化条件,在此基础上进行了多次固定床反应器的连续转化试验(干固定化酶重量为1 kg),以40—44%(w/w)的双酶法液体葡萄糖为底物,在5 ×10~-3MgSO_4,5×10~-3Na_2SO_8,pH7.2.64℃±1℃的条件下,固定化葡萄糖异构酶的半衰期为30天以上,56—60天酶活保留原来的25%。每公斤干固定化酶可转化绝干葡萄糖2吨左右(转化率     

果胶酶固定化方法的研究

用海藻酸钠、二醋酸纤维、明胶分别作为固定化果胶酶的载体,研究比较载体的用量、交联剂的浓度、用酶量、制备的ｐＨ。结果表明,选择１５％浓度的明胶为载体,５％浓度的戊二醛为交联剂,用酶量５％,在ｐＨ３．５条件下制备固定化果胶酶,其酶活力回收率可达６７．７４％,重复回收使用１０次后,酶活力还可保留８０％以上,是果胶酶固定化的一种较好的方法。     

乙二醇缩水甘油醚交联海藻酸钠-羧甲基纤维素钠固定化脂肪酶

以海藻酸钠、羧甲基纤维素钠(CMC)为载体,分别以乙二醇缩水甘油醚(EGDE)和戊二醛为交联剂,采用包埋交联法对脂肪酶进行固定化,结果显示EGDE的交联效果要优于戊二醛,添加EGDE的固定化酶酶活最好。得到制备固定化酶的最优方案为海藻酸钠2.5%,CMC浓度1.5%,给酶量800U/ml复配载体,氯化钙5%,以0.02%的EGDE交联固定30min,由此制备得到酶活约为380 U/g的固定化酶,酶活收率约为50.09%。固定化酶的最适反应p H为8.5,比游离酶增大0.5个单位;最适反应温度是45℃,比游离酶提高5℃;耐热性能变好,且重复使用7次后仍能保持60%左右的相对酶酶活。     

基于海藻酸钠羟基改性的MPEG原位共价修饰微胶囊及抗蛋白性能

目的:通过对海藻酸钠链段羟基位点改性制备甲氧基聚乙二醇(MPEG)原位共价修饰的海藻酸钠/壳聚糖(AC)微胶囊,在保证MPEG修饰微胶囊机械强度不受影响的基础上,有效提高表面MPEG修饰密度,实现兼具良好机械稳定性及抗蛋白性能的微胶囊制备方法。方法:利用溴化氰对海藻酸钠羟基进行活化并将末端氨基的点击化学linker(BAT)接枝在主链上进而制备MPEG原位共价修饰微囊A_(B(OH))CP_N,用球磨法表征微囊机械强度,用Ig G和Fgn为模型考察微囊表面抗蛋白吸附性能,以L929细胞在其二维模拟平板膜上的黏附情况作为衡量指标,考察MPEG修饰微胶囊表面细胞粘附情况,并最终通过体内移植考察MPEG修饰微囊的生物相容性。结果:基于海藻酸钠羟基位点的MPEG原位共价修饰微胶囊能够实现与常规条件制备的微胶囊接近的机械强度;同时与对照组相比Ig G吸附量降低87.4%,Fgn吸附量降低75.5%,实现了良好的抗蛋白吸附性能;二维模拟平板膜表面L929细胞粘附情况显著改善,细胞粘附数与对照组相比降低了76.9%;体内移植结果证明MPEG修饰微囊细胞粘附极少,微囊与纤维层分离明显。结论:基于海藻酸钠羟基位点的MPEG原位修饰能够实现兼具良好机械稳定性及抗蛋白吸附性能的微胶囊。     

果胶酶固定化方法的研究

用海藻酸钠、二醋酸纤维、明胶分别作为固定化果胶酶的载体,研究比较载体的用量、交联剂的浓度、用酶量、制备的ｐＨ。结果表明,选择１５％浓度的明胶为载体,５％浓度的戊二醛为交联剂,用酶量５％,在ｐＨ３．５条件下制备固定化果胶酶,其酶活力回收率可达６７．７４％,重复回收使用１０次后,酶活力还可保留８０％以上,是果胶酶固定化的一种较好的方法。     

Recent advances in the study of Kaposi's sarcoma-associated herpesvirus replication and pathogenesis

It has now been over twenty years since a novel herpesviral genome was identified in Kaposi's sarcoma biopsies. Since then, the cumulative research effort by molecular biologists, virologists, clinicians, and epidemiologists alike has led to the extensive characterization of this tumor virus, Kaposi's sarcoma-associated herpesvirus(KSHV; also known as human herpesvirus 8(HHV-8)), and its associated diseases. Here we review the current knowledge of KSHV biology and pathogenesis, with a particular emphasis on new and exciting advances in the field of epigenetics. We also discuss the development and practicality of various cell culture and animal model systems to study KSHV replication and pathogenesis.     

The structure, reproduction and taxonomy of Vidalia and Osmundaria (Rhodophyta, Rhodomelaceae)

Comprises species occurring mostly in subtidal habitats in tropical, subtropical and warm-temperate areas of the world. An analysis of the type species, V. spiralis (Sonder) Lamouroux ex J. Agardh, a species from Australia, establishes basic characters for distinguishing species in the genus. These characters are (1) branching patterns of thalli, (2) flat blades that may be spiralled on their axis, (3) width of the blade, (4) primary or secondary derivation of sterile and fertile branchlets and (5) position of sterile and fertile branchlets on the thalli. Application of the latter two characters provides an important basic method for separation of species into three major groups. Osmundaria , a genus known only in southern Australia, was studied in relation to Vidalia , and its separation from the Vidalia assemblage is not accepted. Species of Vidalia therefore are transferred to the older genus name, Osmundaria. Two new species, Osmundaria papenfussii and Osmundaria oliveae are described from Natal. Confusion in the usage of the epithet, Vidalia fimbriala Brown ex Turner has been clarified, and Vidalia gregaria Falkenberg, described as an epiphyte on Osmundaria pro/ifera Lamouroux, is revealed to be young branches of the host, Osmundaria prolifera.     

New or rare chromosome counts in Artemisia L. (Asteraceae, Anthemideae) and related genera from Kazakhstan

Fifteen chromosome counts of six Artemisia taxa and one species of each of the genera Brachanthemum, Hippolytia, Kaschgaria, Lepidolopsis and Turaniphytum are reported from Kazakhstan. Three of them are new reports, two are not consistent with previous counts and the remainder are confirmations of very scarce (one to four) earlier records. All the populations studied have the same basic chromosome number, x = 9, with ploidy levels ranging from 2x to 6x. Some correlations between ploidy level, morphological characters and distribution are noted.     

肝癌中HBV和HCV基因和抗原的分布及意义

采用原位分子杂交方法检测HCV RNA及HBV X基因;采用免疫组织化学方法研究HCV核心抗原,非结构区C33c抗原及HBxAg在肝细胞肝癌中的定位及分布.结果表明(1)HCV RNA、HBV X基因在肝细胞肝癌组织检出率分别为40%(55/136)和82%(112/136).HCV RNA定位于癌细胞的胞浆内,阳性细胞呈散在、灶状及弥漫分布三种形式;HBV X基因在肝癌细胞中的分布呈胞浆型、核型及核浆型,阳性细胞也呈上述三种分布形式;(2)HCV C33c抗原、核心抗原在肝细胞肝癌中的阳性率为81%(133/164)及86%(141/164).C33c抗原定位于癌细胞及肝细胞的胞浆内;核心抗原既定位于癌细胞核中,又可定位于胞浆中.C33c抗原阳性细胞以灶状分布为主;而核心抗原阳性细     

Selection with two alleles and complete dominance

For a plant selection model with frequency-independent viabilities, fertilities and selfing rates, it is shown that apart from global fixation, for certain parameter combinations a protected polymorphism and facultative fixation (either allele may become fixed according to initial frequencies) may both occur. Facultative fixation requires different selling rates for the dominant and recessive type. Protection of the polymorphism requires resource allocation for male and female function. In this connection the problem of purely genetically caused population extinction is discussed.
For general frequency dependence and regular segregation, the chances for establishment of a completely recessive gene are compared to those of a completely dominant gene. It is proven that the process of establishment of the recessive gene, despite a fitness advantage, may be considerably endangered by drift effects if random mating prevails. The recessive gene may reach the same effectivity in establishment as a dominant gene, only if the recessive homozygote mates exclusively with its own type during the period of establishment.